Trial
NCT01285505
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Healthy
Intervention
alprazolam commercial sublingual formulation
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-28